Profile
5AM Ventures is a venture capital firm based in San Francisco, California, founded in 2002. The firm is led by a team of 29 professionals, including 9 partners, with expertise in scientific, medical, operational, legal, and financial fields. 5AM Ventures is known for its hands-on approach, particularly through its 4:59 Initiative, which focuses on discovering, incubating, and funding breakthrough science in collaboration with academics and entrepreneurs.
The firm primarily invests in early-stage life sciences companies, with a focus on sectors such as biotechnology, health technology, and digital health. 5AM Ventures typically invests in Series A rounds, with check sizes ranging from $100K to $5M. The firm has a strong presence in the United States and has a portfolio that includes both private therapeutic companies and small to mid-cap public biotech firms.
Notable investments by 5AM Ventures include companies like Ideaya Biosciences - oncology therapeutics, Crinetics - endocrine therapies, MapLight Therapeutics - neuroscience, Ensoma - gene therapy, and Kinaset Therapeutics - respiratory treatments. The firm has seen several successful exits, including IPOs and acquisitions.
Industry
5AM Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
5AM Ventures IV, L.P.
|
Venture Capital (VC)
|
Biotechnology
Pharmaceuticals
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$250 M
|
September 2013
|
|
5AM Ventures V, L.P.
|
Venture Capital (VC)
|
Biotechnology
Pharmaceuticals
Life Sciences
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$285 M
|
May 2016
|
|
5AM Ventures VI
|
Venture Capital (VC)
|
Biotechnology
Pharmaceuticals
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$350 M
|
February 2019
|
|
5AM Ventures VII, L.P
|
Venture Capital (VC)
|
Biotechnology
Pharmaceuticals
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$450 M
|
April 2022
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.